A comprehensive information resource about exposure to diethylstilbestrol
(DES) is now available on the Internet for clinicians, consumers, and others
(http://www.cdc.gov/DES). The resource, "DES Update," was launched
in March by the Centers for Disease Control and Prevention (CDC).
DES is a synthetic estrogen first prescribed in 1938 for women who experienced
miscarriages or premature deliveries. Prescriptions for pregnant women were
banned in 1971 by the Food and Drug Administration after research linked DES
to a rare vaginal cancer, clear cell adenocarcinoma, in female offspring (N Engl J Med. 1971;284:878-881).
Mitka M. CDC Resource Focuses on DES Exposure. JAMA. 2003;289(13):1624. doi:10.1001/jama.289.13.1624
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: